You searched for: chronic disease
1 to 4 of 4 results
Show
results per page
Matched phrases in profile:
Disease burden and productivity cost of chronic rhinosinusitis patients referred to a tertiary centre in Australia… Probiotic treatment of Chronic Rhinosinusits… The role of the bacterial, fungal and viral sinus microbiome in chronic rhinosinusitis patients… The overall aim of the project is to improve quality of life in patients suffering from Chronic… Chronic sinusitis… function in the upper airways, the role of Nitric Oxide in chronic sinusitis, the use of macrolide… mechanisms by which macrolides reduce inflammation in chronic airway disease. Discrepancies between the…
Professor Anders Cervin has a longstanding interest in sino-nasal disorders, endoscopic sinus surgery as well as endoscopic anterior skull base surgery. His research interests includes mucociliary function in the upper airways, the role of Nitric Oxide in chronic sinusitis, the use of macrolide anti …
Treatment of Chronic Sinusits and Middle Ear Infections (Otitis Media) with Probiotics
Chronic rhinosinusitis (CRS) affects 8-10% of the western population, mainly middle-aged adults in the prime of their working life, and causes a significant reduction in quality of life. Although unproven the mai …
Matched phrases in profile:
in patients with Chronic Kidney Disease: a randomised controlled trial… Adiponectin - A Link Between Obesity, Insulin Resistance And The Development Of Chronic Disease… translating scientific evidence into improved clinical care for people with complex chronic conditions. From… chronic disease. Resveratrol, a polyphenol found in the skin of grapes, and other edible plants and…
A/Prof Ingrid Hickman is a Principal Research Fellow in Implementation Science with the UQ ULTRA team (Clinical Trial Capability) located within the Centre for Clinical Research in Herston. A/Prof Ingrid Hickman is an implementation scientist and has over 20 years experience in health services clini …
A/Prof Hickman is well placed to link scientific discoveries and clinical practice. Her experience with delivering clinical trials within the health care system provides methodological expertise in designing hybrid implementation effectiveness trials to increase the speed at which cliical trials are …
Matched phrases in profile:
This project aims to help understand motor neurone disease, which is a severe disease that leads to… One of the challenges of ALS is understanding disease heterogeneity. Our work studies the… syndrome and chronic inflammatory demyelinating polyradiculoneuropathy… Role and specificity of T cells and B cells in chronic autoimmune demyelinating disease… Neuromuscular disease… to a state of chronic energy deficit which has a negative impact on disease outcome in ALS. We…
Neurologist
Dr McCombe graduated in Medicine from UQ and completed a Science degree for medical students. She then trained as a neurologist in Sydney, at Prince Henry and Prince of Wales Hospitals. She obtained a PhD from the University of Sydney. She obtained experience in Neurophysiology in Cleve …
Matched phrases in profile:
Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of parkinson’s disease… Novel therapeutic strategies targeting the microbiota and gut-brain axis in Parkinson's disease… Repurposing of clinically validated kinase inhibitors to block chronic neuroinflammation and disease progression in Parkinson's disease… changes seen in Parkinson's disease (PD) and other neurological disorders. Clinical studies suggest that… Clinical bio-markers for early detection of Parkinson's disease… mechanisms which drive the onset and progression of neurodegenerative disorders such as Parkinson’s disease… other related chronic neurodegenerative diseases. PK2 signals through its receptors on astrocytes and…
Dr. Richard Gordon leads a multi-disciplinary, industry-partnered research program in Translational Neuroscience which integrates immunology, drug development, pharmacology, metabolomics and microbial metagenomics. His group aims to understand and therapeutically target key pathological mechanisms w …
Dr. Gordon’s research has contributed to ground-breaking advances in the field of neuroinflammation and Parkinson’s disease, including discovery of a novel signalling paradigm for prokineticin signalling during neurodegeneration, and inflammasome activation as a driver of synuclein pathology and …
1 to 4 of 4 results